Roche Diagnostics Cobas Integra Cocaine II

Land: Singapore

Sprog: engelsk

Kilde: HSA (Health Sciences Authority)

Tilgængelig fra:

Roche Diagnostics Asia Pacific Pte Ltd

Klasse:

Class B IVD

Fremstillet af:

Roche Diagnostics GmbH

Terapeutisk område:

Clinical toxicology

Terapeutiske indikationer:

Roche Diagnostics Cobas Integra Cocaine II (COCII) is an in vitro diagnostic test intended for the semiquantitative and qualitative detection of benzoylecgonine, the primary metabolite of cocaine, in human urine at cutoff concentrations of 150 ng/mL and 300 ng/mL on COBAS INTEGRA systems

Produkt oversigt:

Models: COBAS INTEGRA Cocaine II - 03800130190, Preciset DAT Plus I - 03304671190, Control Set DAT I - 03312950190, Control Set DAT III - 03312976190, Control Set DAT Clinical - 04500873190, C.f.a.s. DAT Qualitative Plus - 03304698190, C.f.a.s. DAT Qualitative Plus Clinical - 04590856190, cobas Integra 400 plus - 03245233001, cobas Integra 400 plus software version 3.5.2 - 05636957001, cobas Integra 400 plus software version 3.4.4 - 05215242001, Cleaner - 20754765322, CLEAN Cleaner Cassette - 20764337322, NaCl Diluent 9% - 20756350322, SI2 Serum Index Gen.2 - 04489365190, SDR II COBAS FP Sample Dilution Reagent II - 20720720322, MULTI Single use reagent carrier - 04593138190, Waste Container COBAS Integra 400 - 21046179001, Cup Sample White with hole - 21045318001, Cup Sample Blue with hole - 21044869001, Cuvette COBAS Integra - 21043862001

Autorisation dato:

2014-01-24